MLTX
NASDAQ · Biotechnology
Moonlake Immunotherapeutics
$18.86
+1.80 (+10.55%)
Open$17.94
Previous Close$17.06
Day High$19.07
Day Low$17.84
52W High$62.75
52W Low$5.95
Volume—
Avg Volume656.7K
Market Cap1.25B
P/E Ratio—
EPS$-3.52
SectorBiotechnology
Analyst Ratings
Strong Buy
23 analysts
Price Target
-44.1% upside
Current
$18.86
$18.86
Target
$10.54
$10.54
$8.06
$10.54 avg
$16.98
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 207.37M | 195.61M | 178.47M |
| Net Income | -41,056,867 | -38,376,149 | -44,335,912 |
| Profit Margin | -19.8% | -19.6% | -24.8% |
| EBITDA | -81,449,014 | -69,654,675 | -60,804,840 |
| Free Cash Flow | -45,845,658 | -33,391,408 | -32,934,200 |
| Rev Growth | +19.2% | +9.7% | +1.7% |
| Debt/Equity | 0.11 | 0.10 | 0.12 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |